BackDexin Overview

Dexin Receivables

Dexin's receivables is $53M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$52.54M
↓ 53.71% YoYΔ $-60.95M vs prior year quarter

Peer trimmed avg / median

Loading

Dexin Receivables History

Loading

Dexin vs. peers: Receivables Comparison

Loading

Dexin Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Dexin (3349.TWO) FAQ

Dexin (3349.TWO) currently reports a receivables of $53M as of June 2026. That compares with $110M in the prior-year period — down 53.7% year over year. Use the charts on this page to explore Dexin's receivables history and peer comparisons.

Dexin's receivables decreased from $110M to $53M — a 53.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Dexin reported $53M in receivables as of June 2026. That compares with $110M in the prior-year period — down 53.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $53M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Dexin, and consider following 3349.TWO for alerts when major investors trade the stock.